MNMD - Mind Medicine Inc

MNMD - Mind Medicine Inc

https://www.mindmed.co

Buy Momentum: Bearish

Recent News

Powered by Alpha Vantage

If You'd Invested $1,000 in Mind Medicine ( MNMD ) Stock 5 Years Ago, Here's How Much You'd Have Today

Motley Fool • 1 month ago • score: 0.34

Mind Medicine stock hasn't beaten the market over the last five years, but what comes next?

Is Anixa Biosciences ( ANIX ) Stock Outpacing Its Medical Peers This Year?

Zacks Commentary • 1 month, 3 weeks ago • score: 0.21

Here is how ANIXA BIOSCIENCES INC (ANIX) and Mind Medicine (MindMed) Inc. (MNMD) have performed compared to their sector so far this year.

All You Need to Know About Mind Medicine MindMed ( MNMD ) Rating Upgrade to Buy

Zacks Commentary • 1 month, 3 weeks ago • score: 0.32

Mind Medicine MindMed (MNMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Why Mind Medicine Gave Investors a Powerful Buzz in May

Motley Fool • 3 months, 1 week ago • score: 0.40

Mind Medicine ( NASDAQ: MNMD ) , a healthcare company that's looking to develop treatments based on psychedelic compounds, was something of a sleeper stock in May. Several positive developments pushed the highly specialized enterprise's share price higher, to the point where it closed the month ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

Mind Medicine (MindMed) Inc., a psychedelic medicine biotechnology company, discovers, develops and deploys psychedelic-inspired medicines and therapies to address addiction and mental illness. The company is headquartered in New York, New York.

52W High

$11.02

52W Low

$4.70

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

2.97

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-6.57

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

3.78

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

0.84%

Institutions (25–75% balanced)

55.69%

Shares Outstanding

76,088,000

Float

70,246,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

0

Gross Profit (TTM)

0

EPS (TTM)

-1.34

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-0.59%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

0.0332

Previous

0.0395

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025